Globenewswire

INVENTIVA

26.1.2026 22:00:00 CET | Globenewswire | Press release

Share

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux

Daix (France), New York City (New York, United States), January 26, 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with metabolic dysfunction-associated steatohepatitis (“MASH”), today announced the half-year report of its liquidity contract with Kepler Cheuvreux.

Under the liquidity contract granted to Kepler Cheuvreux by Inventiva, the following resources were available in the liquidity account as of 31 December 2025:

  • Cash: € 526,751.56
  • Number of shares: 58,515 
  • Number of executions on buy side on semester: 2,332
  • Number of executions on sell side on semester: 2,741
  • Traded volume on buy side on semester: 550,198 shares for € 2,093,559.19
  • Traded volume on sell side on semester: 576,215 shares for € 2,189,327.66

At the last half-year report as of 30 June 2025 the following resources were available in the liquidity account:

  • Cash: € 428,212.57
  • Number of shares: 84,532
  • Number of executions on buy side on semester: 1,642
  • Number of executions on sell side on semester: 1,878
  • Traded volume on buy side on semester: 267,584 shares for € 744,692.94
  • Traded volume on sell side on semester: 296,504 shares for € 819,771.51

When the contract was initially implemented, the following resources were included in the liquidity account:

  • Cash: € 163,510.42
  • Number of shares: 34,063
 Buy Side Sell Side
 Number of
executions		Number of
shares		Traded volume in EUR Number of
executions		Number of
shares		Traded volume in EUR
Total2,332550,1982,093,559.19 2,741576,2152,189,327.66
07/01/2025142,6136,846.06 101,2363,275.40
07/02/2025183,3728,699.76 ---
07/03/202591,5013,977.65 498,03721,378.42
07/04/2025172,9997,917.36 25001,325.00
07/07/2025211,5164,017.40 193,3428,923.14
07/08/202548372,293.38 375,72015,730.00
07/09/2025101,7504,830.00 212,5006,975.00
07/10/202557782,155.06 101,0012,782.78
07/11/202581,6074,467.46 161,9995,597.20
07/14/2025182,8787,885.72 55501,518.00
07/15/20253252690.48 202,5006,900.00
07/16/202571,4984,149.46 131,9775,515.83
07/17/20251250695.00 101,0232,843.94
07/18/202581,0002,760.00 4240669.60
07/21/2025152,2706,197.10 1250685.00
07/22/202561,0002,750.00 273,76010,377.60
07/23/2025335,73015,757.50 356,45017,995.50
07/24/202581,7504,742.50 ---
07/25/2025--- 41,0002,780.00
07/28/2025214,75013,347.50 427,75322,173.58
07/29/20252250725.00 7511,15432,346.60
07/30/2025274,53112,958.66 101,6154,731.95
07/31/2025203,96911,192.58 254,75013,585.00
08/01/2025172,7507,755.00 71,2513,590.37
08/04/2025112,5006,950.00 51,0312,876.49
08/05/2025131,7504,935.00 121,7194,864.77
08/06/2025111,9845,555.20 193,53910,050.76
08/07/2025213,0008,700.00 223,4119,994.23
08/08/2025122,0675,932.29 212,0495,962.59
08/11/2025102,0005,840.00 212,2506,592.50
08/12/20252279825.84 283,75011,137.50
08/13/2025222,9018,993.10 669,75030,615.00
08/14/202547502,527.50 6510,99937,396.60
08/15/2025183,75012,862.50 142,0507,154.50
08/18/202537502,535.00 345,70020,406.00
08/19/2025163,25012,382.50 679,00034,740.00
08/20/2025112,5009,650.00 143,04011,825.60
08/21/2025294,10815,651.48 163,46013,390.20
08/22/2025142,99211,459.36 101,7516,811.39
08/25/202571,7506,772.50 396,75027,067.50
08/26/2025142,75011,110.00 193,25013,292.50
08/27/2025--- 7512,25054,145.00
08/28/2025204,00019,320.00 387,00034,440.00
08/29/2025286,25029,500.00 405,75027,887.50
09/01/2025366,75031,792.50 101,5007,560.00
09/02/2025163,00013,260.00 102,25010,125.00
09/03/2025--- 275,00023,400.00
09/04/20253413,00058,760.00 ---
09/05/202563,95517,599.75 22,0009,000.00
09/08/20252712,00052,320.00 710,00044,000.00
09/09/202512,0008,900.00 810,00045,500.00
09/10/2025--- 34,00018,600.00
09/11/2025--- 31,0004,750.00
09/12/202547503,487.50 ---
09/15/202532,50011,300.00 22501,195.00
09/16/202543,50015,575.00 21,0004,500.00
09/17/202567,00030,170.00 54,00017,360.00
09/18/2025--- 123,00013,560.00
09/19/2025--- 42,0009,240.00
09/22/2025162,34510,904.25 183,25015,307.50
09/23/2025295,75027,025.00 326,50030,810.00
09/24/2025305,27824,912.16 163,50016,765.00
09/25/2025--- 346,95534,427.25
09/26/2025316,75033,075.00 336,25031,000.00
09/29/2025409,50046,930.00 357,00035,280.00
09/30/2025398,00038,560.00 203,75018,337.50
10/01/2025142,75113,554.95 336,25031,270.00
10/02/2025122,75013,970.00 387,33537,921.95
10/03/2025378,00042,640.00 416,25033,625.00
10/06/2025479,25047,452.50 131,5007,755.00
10/07/2025408,24941,162.51 243,75019,387.50
10/08/2025478,72240,470.08 203,04714,503.72
10/09/20254910,90046,216.00 356,00025,620.00
10/10/2025419,25037,185.00 274,75019,380.00
10/13/2025529,90038,412.00 122,75010,917.50
10/14/2025306,50023,855.00 5612,00046,200.00
10/15/2025378,00030,880.00 133,00011,760.00
10/16/2025275,75020,757.50 265,06918,856.68
10/17/2025306,25021,625.00 214,00013,960.00
10/20/2025306,75022,545.00 133,25010,985.00
10/21/2025153,50011,550.00 162,7509,212.50
10/22/2025296,60021,054.00 92,0006,400.00
10/23/2025234,89915,039.93 194,50013,950.00
10/24/2025184,00012,280.00 173,47410,977.84
10/27/2025133,0009,210.00 447,50023,325.00
10/28/2025133,25010,562.50 7213,52644,500.54
10/29/20255212,00039,600.00 9520,18174,669.70
10/30/2025478,75530,467.40 37502,625.00
10/31/202551,2504,500.00 336,75024,435.00
11/03/2025357,29526,043.15 264,57416,740.84
11/04/2025213,00510,547.55 347,17725,837.20
11/05/2025264,60616,489.48 92,2508,190.00
11/06/2025122,0507,646.50 397,50028,350.00
11/07/2025245,34419,398.72 51,2504,650.00
11/10/2025398,49529,052.90 47502,685.00
11/11/2025122,2507,312.50 ---
11/12/202561,5005,040.00 264,50015,210.00
11/13/202592,2507,245.00 37502,430.00
11/14/202592,2507,177.50 122,5008,325.00
11/17/2025102,5008,575.00 468,00028,080.00
11/18/2025223,75012,975.00 111,5005,235.00
11/19/2025143,00010,410.00 143,50012,285.00
11/20/2025172,7509,570.00 184,25015,130.00
11/21/2025284,89517,132.50 82,0007,100.00
11/24/2025132,8009,660.00 304,00014,000.00
11/25/2025153,30712,037.48 5110,00036,900.00
11/26/20253612,00045,960.00 3411,52045,388.80
11/27/2025176,50024,245.00 309,00034,110.00
11/28/2025214,44316,261.38 15001,850.00
12/01/202562,0007,240.00 41,0003,690.00
12/02/20252812,50046,750.00 177,50028,725.00
12/03/20254814,25549,607.40 ---
12/04/2025165,50019,140.00 145,00017,550.00
12/05/2025224,50015,705.00 72,5068,821.12
12/08/202592,5008,700.00 216,91224,192.00
12/09/2025125,00017,750.00 258,08229,014.38
12/10/2025236,20622,713.96 3111,06041,475.00
12/11/2025187,00026,180.00 165,00019,000.00
12/12/202552,0007,520.00 180308.80
12/15/2025269,00033,750.00 155,50020,900.00
12/16/2025239,29433,830.16 218,00129,523.69
12/17/2025136,00022,620.00 299,35935,844.97
12/18/2025188,00030,320.00 176,94327,216.56
12/19/2025229,50034,675.00 135,00018,450.00
12/22/2025216,50023,335.00 228,00029,280.00
12/23/2025227,50028,800.00 2910,49440,821.66
12/24/2025124,35316,280.22 104,00015,160.00
12/29/2025464239.36 133,56313,681.92
12/30/202551,0003,880.00 31,5005,910.00
12/31/202551,0003,870.00 25001,960.00

About Inventiva

Inventiva is a clinical-stage biopharmaceutical company focused on the research and development of oral small molecule therapies for the treatment of patients with MASH and other diseases with significant unmet medical need. The Company is currently evaluating lanifibranor, a novel pan-PPAR agonist, in the NATiV3 pivotal Phase 3 clinical trial for the treatment of adult patients with MASH, a common and progressive chronic liver disease.  

Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: FR0013233012) and on the Nasdaq Global Market in the United States (ticker: IVA). http://www.inventivapharma.com

Contacts

Inventiva

Pascaline Clerc, PhD
EVP, External and Corporate Affairs
    media@inventivapharma.com
   +1 202 499 8937		ICR Healthcare
Alexis Feinberg
Media Relations
inventivapr@icrhealthcare.com
+1 203 939 2225

 		ICR Healthcare
Patricia L. Bank
Investor Relations
         patti.bank@icrhealthcare.com  

         +1 415 513 1284

Attachment


Documents

Subscribe to releases from Globenewswire

Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Globenewswire

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye